David D. Allison - 07 Oct 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Oct 2022
Net transactions value
+$12,497
Form type
4
Filing time
12 Oct 2022, 16:28:38 UTC
Previous filing
20 Jul 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Stock Option (Right to Buy) Award $12,497 +524 $23.85 524 07 Oct 2022 Common Stock 524 $33.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of retainer fees of $12,500.